NCT01186133Recruiting
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50000 (estimated)
- First submitted
- 19 Aug 2010
- Start date
- Jan 2009
- Primary completion date
- Dec 2030
- Lead sponsor
- Seung-Jung Park
- Diseases
- Coronary artery disease
- NCT number
- NCT01186133
What you commit to
- Study type: Observational
- Planned participants: 50000
- From Jan 2009 to the primary completion date, Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- terminal illness with life expectancy less than 1 year
Other
- patients with a mixture of several DES
- patients with cardiogenic shock
Who the study is looking for
- coronary disease amenable to percutaneous coronary intervention (PCI)
- no clinical and lesion limitations
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Korean centres Coordinator of this site? Confirm its status | Multiple Locations | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.